Oxford University, United Kingdom Scientists have started a clinical trial for a novel HIV vaccine.
The trial known as HIV-CORE 0052 began on Monday.
According to Oxford the goal of the trial, is to evaluate the safety, tolerability, and immunogenicity of the HIVconsvX vaccine – a mosaic vaccine targeting a broad range of HIV-1 variants, making it potentially applicable for HIV strains in...Continue reading
0 Comments